BIOA

insider transactions

BioAge Labs, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-291.2K

0 buy · 291.2K sell

Net value · 365d

-$5.3M

$0 in · $5.3M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 291.2K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Jun 10, 26

Vijay Satyanand Pande

Director

$0

22.0K sh

Own New
Grant·A
Jun 10, 26

Rekha Hemrajani

Director

$0

22.0K sh

Own New
Grant·A
Jun 10, 26

Michael H. Davidson

Director

$0

22.0K sh

Own New
Grant·A
Jun 10, 26

Patrick G Enright

Director

$0

22.0K sh

Own New
Grant·A
Jun 10, 26

James Healy

Director

$0

22.0K sh

Own New
Grant·A
Jun 10, 26

Jean Pierre Garnier

Director

$0

22.0K sh

Own New
Exercise·M
Apr 23, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer

$0

3.5K sh

Own +2%
Exercise·M
Apr 23, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer

$15.5K

3.5K sh · $4.38

Own +11%
Exercise·M
Apr 1, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$0

3.4K sh

Own New
Exercise·M
Apr 1, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$0

5.4K sh

Own New
Sell·S
Apr 1, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$157.1K

8.8K sh · $17.81

Own -100%
Exercise·M
Apr 1, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$22.2K

3.4K sh · $6.57

Own +62%
Exercise·M
Apr 1, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$22.3K

5.4K sh · $4.11

Own New
Exercise·M
Mar 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$0

2.0K sh

Own +145%
Exercise·M
Mar 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$0

5.4K sh

Own +135825%
Sell·S
Mar 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$150.9K

7.4K sh · $20.30

Own -100%
Exercise·M
Mar 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$13.1K

2.0K sh · $6.57

Own +37%
Exercise·M
Mar 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$22.3K

5.4K sh · $4.11

Own New
Exercise·M
Mar 1, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer

$0

3.5K sh

Own +2%
Exercise·M
Mar 1, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer

$15.5K

3.5K sh · $4.38

Own +12%
Grant·A
Feb 17, 26

Eric Morgen

Chief Operating Officer

$0

12.5K sh

Own New
Grant·A
Feb 17, 26

Eric Morgen

Chief Operating Officer

$0

110.0K sh

Own New
Grant·A
Feb 17, 26

Kristen Fortney KEY

Chief Executive Officer

$0

330.0K sh

Own New
Grant·A
Feb 17, 26

Paul D Rubin

Chief Medical Officer

$0

110.0K sh

Own New
Grant·A
Feb 17, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer

$0

110.0K sh

Own New
Grant·A
Feb 17, 26

Shane Barton

Principal Accounting Officer

$0

45.0K sh

Own New
Exercise·M
Feb 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$0

2.0K sh

Own +59%
Exercise·M
Feb 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$0

5.4K sh

Own +100%
Sell·S
Feb 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$139.4K

7.4K sh · $18.75

Own -100%
Exercise·M
Feb 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$13.1K

2.0K sh · $6.57

Own +37%
Exercise·M
Feb 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$22.3K

5.4K sh · $4.11

Own New
Exercise·M
Feb 1, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer

$0

3.5K sh

Own +2%
Exercise·M
Feb 1, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer

$15.5K

3.5K sh · $4.38

Own +14%
Exercise·M
Jan 16, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer

$0

3.5K sh

Own +2%
Exercise·M
Jan 16, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer

$15.5K

3.5K sh · $4.38

Own +16%
Sell·S
Jan 13, 26

Kristen Fortney KEY

Chief Executive Officer · 10b5-1

$4.2M

233.1K sh · $18.12

Own -19%
Exercise·M
Jan 13, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer · 10b5-1

$0

27.0K sh

Own +41%
Sell·S
Jan 13, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer · 10b5-1

$40.5K

1.9K sh · $21.08

Own -8%
Sell·S
Jan 13, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer · 10b5-1

$239.5K

11.7K sh · $20.54

Own -32%
Sell·S
Jan 13, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer · 10b5-1

$86.4K

4.4K sh · $19.45

Own -11%
Sell·S
Jan 13, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer · 10b5-1

$165.4K

9.0K sh · $18.43

Own -18%
Exercise·M
Jan 13, 26

GOLDSTEIN DOV A MD KEY

Chief Financial Officer · 10b5-1

$226.5K

27.0K sh · $8.39

Own +120%
Exercise·M
Jan 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$0

2.0K sh

Own +37%
Exercise·M
Jan 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$0

5.4K sh

Own +50%
Sell·S
Jan 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$95.5K

7.4K sh · $12.85

Own -100%
Exercise·M
Jan 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$13.1K

2.0K sh · $6.57

Own +37%
Exercise·M
Jan 2, 26

Paul D Rubin

Chief Medical Officer · 10b5-1

$22.3K

5.4K sh · $4.11

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 10, 2026	Vijay Satyanand Pande	Director	Grant A	22.0K	New	—	$0
Jun 10, 2026	Rekha Hemrajani	Director	Grant A	22.0K	New	—	$0
Jun 10, 2026	Michael H. Davidson	Director	Grant A	22.0K	New	—	$0
Jun 10, 2026	Patrick G Enright	Director	Grant A	22.0K	New	—	$0
Jun 10, 2026	James Healy	Director	Grant A	22.0K	New	—	$0
Jun 10, 2026	Jean Pierre Garnier	Director	Grant A	22.0K	New	—	$0
Apr 23, 2026	GOLDSTEIN DOV A MD KEY	Chief Financial Officer	Exercise M	3.5K	+2%	—	$0
Apr 23, 2026	GOLDSTEIN DOV A MD KEY	Chief Financial Officer	Exercise M	3.5K	+11%	$4.38	$15.5K
Apr 1, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	3.4K	New	—	$0
Apr 1, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	5.4K	New	—	$0
Apr 1, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Sell S	8.8K	-100%	$17.81	$157.1K
Apr 1, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	3.4K	+62%	$6.57	$22.2K
Apr 1, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	5.4K	New	$4.11	$22.3K
Mar 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	2.0K	+145%	—	$0
Mar 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	5.4K	+135825%	—	$0
Mar 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Sell S	7.4K	-100%	$20.30	$150.9K
Mar 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	2.0K	+37%	$6.57	$13.1K
Mar 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	5.4K	New	$4.11	$22.3K
Mar 1, 2026	GOLDSTEIN DOV A MD KEY	Chief Financial Officer	Exercise M	3.5K	+2%	—	$0
Mar 1, 2026	GOLDSTEIN DOV A MD KEY	Chief Financial Officer	Exercise M	3.5K	+12%	$4.38	$15.5K
Feb 17, 2026	Eric Morgen	Chief Operating Officer	Grant A	12.5K	New	—	$0
Feb 17, 2026	Eric Morgen	Chief Operating Officer	Grant A	110.0K	New	—	$0
Feb 17, 2026	Kristen Fortney KEY	Chief Executive Officer	Grant A	330.0K	New	—	$0
Feb 17, 2026	Paul D Rubin	Chief Medical Officer	Grant A	110.0K	New	—	$0
Feb 17, 2026	GOLDSTEIN DOV A MD KEY	Chief Financial Officer	Grant A	110.0K	New	—	$0
Feb 17, 2026	Shane Barton	Principal Accounting Officer	Grant A	45.0K	New	—	$0
Feb 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	2.0K	+59%	—	$0
Feb 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	5.4K	+100%	—	$0
Feb 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Sell S	7.4K	-100%	$18.75	$139.4K
Feb 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	2.0K	+37%	$6.57	$13.1K
Feb 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	5.4K	New	$4.11	$22.3K
Feb 1, 2026	GOLDSTEIN DOV A MD KEY	Chief Financial Officer	Exercise M	3.5K	+2%	—	$0
Feb 1, 2026	GOLDSTEIN DOV A MD KEY	Chief Financial Officer	Exercise M	3.5K	+14%	$4.38	$15.5K
Jan 16, 2026	GOLDSTEIN DOV A MD KEY	Chief Financial Officer	Exercise M	3.5K	+2%	—	$0
Jan 16, 2026	GOLDSTEIN DOV A MD KEY	Chief Financial Officer	Exercise M	3.5K	+16%	$4.38	$15.5K
Jan 13, 2026	Kristen Fortney KEY 10b5-1	Chief Executive Officer	Sell S	233.1K	-19%	$18.12	$4.2M
Jan 13, 2026	GOLDSTEIN DOV A MD KEY 10b5-1	Chief Financial Officer	Exercise M	27.0K	+41%	—	$0
Jan 13, 2026	GOLDSTEIN DOV A MD KEY 10b5-1	Chief Financial Officer	Sell S	1.9K	-8%	$21.08	$40.5K
Jan 13, 2026	GOLDSTEIN DOV A MD KEY 10b5-1	Chief Financial Officer	Sell S	11.7K	-32%	$20.54	$239.5K
Jan 13, 2026	GOLDSTEIN DOV A MD KEY 10b5-1	Chief Financial Officer	Sell S	4.4K	-11%	$19.45	$86.4K
Jan 13, 2026	GOLDSTEIN DOV A MD KEY 10b5-1	Chief Financial Officer	Sell S	9.0K	-18%	$18.43	$165.4K
Jan 13, 2026	GOLDSTEIN DOV A MD KEY 10b5-1	Chief Financial Officer	Exercise M	27.0K	+120%	$8.39	$226.5K
Jan 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	2.0K	+37%	—	$0
Jan 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	5.4K	+50%	—	$0
Jan 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Sell S	7.4K	-100%	$12.85	$95.5K
Jan 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	2.0K	+37%	$6.57	$13.1K
Jan 2, 2026	Paul D Rubin 10b5-1	Chief Medical Officer	Exercise M	5.4K	New	$4.11	$22.3K

About BIOA insider trading

This page tracks insider transactions for BioAge Labs, Inc. (BIOA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.